Latest filing published 18 Mar 2026 for AMETEK INC/, €175k.
Anthony James Conti signed 38 filings from May 5, 2016 to March 18, 2026, as Director of Ametek Inc/ (32) and Biotelemetry, Inc. (6). Volume has fallen sharply: 7 filings in 2020, then a single one a year in 2024, 2025 and 2026. The latest, published March 18, 2026, is the only one in the last twelve months, and it is neither a purchase nor a sale.
On the market, 10 sales weigh EUR 2,769,163 in total, median EUR 266,321. The three largest all fall in March: EUR 625,082 on March 25, 2022, EUR 447,906 on March 21, 2023 and EUR 336,438 on March 12, 2019. No purchase. On top come 17 share grants, 10 option exercises and one filing of another kind.
At Ametek, colleagues trade in the same weeks: 6 of Conti's trades fall within 30 days of trades by Steven W. Kohlhagen, 5 of Ronald J. Oscher's and 5 of Timothy N. Jones's, in the same direction every time. Filings are published a median of 1 day after the trade.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 38 declarations